Prosecution Insights
Last updated: October 02, 2026

Anacyte Laboratories GmbH

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Anacyte Laboratories GmbH is currently managing 1 pending office action. This active case is being handled by 1 distinct examiner. The records indicate 0 distinct art units associated with this portfolio, suggesting a unique or early-stage filing status for the company's current intellectual property. This focused activity indicates a very specific technical goal for the current patent strategy.

FRITCHMAN, REBECCA M is identified as the busiest examiner, with 1 pending office action under their review. As there is only 1 distinct examiner listed, this individual is the sole point of contact for the company's current pending matters. This represents a very small and concentrated prosecution profile, allowing for direct communication between the examiner and the company's representatives.

With 1 pending office action and 0 distinct art units, the portfolio is currently in a highly specialized state. The company's interaction with the patent office is limited to this single matter. This data reflects a portfolio that is either in its infancy or is extremely targeted in its technical scope, requiring minimal coordination across different patent office departments for the 1 distinct examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FRITCHMAN, REBECCA M 1 45.7% +35.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18689552 SOLUTION FOR THE PRESERVATION OF CELLS FRITCHMAN, REBECCA M —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18689552 SOLUTION FOR THE PRESERVATION OF CELLS FRITCHMAN, REBECCA M —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18689552 SOLUTION FOR THE PRESERVATION OF CELLS FRITCHMAN, REBECCA M — §101§103§112 Non-Final OA — Pending Mar 06, 2024

Managing Anacyte Laboratories GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month